secwatch / observer
8-K filed March 25, 2026, 7:59 PM ET ticker QUCY CIK 0001874252
regulatory confidence high sentiment negative materiality 0.75

Quantum Cyber N.V. (QUCY): Nasdaq/NYSE listing notice — Mainz Biomed receives Nasdaq minimum bid price deficiency notice; 180-day cure period until Sep 16, 2026

Quantum Cyber N.V.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.98

Quantum Cyber N.V. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

Exchange
nasdaq
Notice
deficiency notice
Deficiency
minimum bid price
Rules
5550(a)(2), 5810(c)(3)(A)
Exact text from the filing
March 20, 2026, Mainz Biomed N.V. (the “ Company ”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market indicating that, based upon the closing bid price of the Company’s ordinary shares, nominal value €0.01 per share (the “ Ordinary Shares ”) for the 30 consecutive business days between February 5, 2026, to March 19, 2026, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market (“ Nasdaq ”) pursuant to Nasdaq Listing Rule 5550(a)(2). The letter also indicated that the Company will be prov
View on SEC.gov

20 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Quantum Cyber N.V. filing history →

Source: SEC EDGAR
accession 0001213900-26-034103
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.